GADWith further clinical trials, this form of gene therapy will hopefully improve the lives of individuals with Parkinson's disease who do not benefit from drugs.
Saturday, March 19, 2011
Gene Therapy Trial For Parkinson's Disease Effective In Improving Motor Function
This article discusses a clinical trial in which patients with Parkinson's Disease who were injected with the GAD (glutamic acid decarboxylase) gene improved in their motor functioning. The GAD gene was injected directly into their brain and the enzyme produces GABA, a chemical involved in motor coordination that is low in individuals with PD. This was a double-blind clinical trial that involved 22 individuals who received the gene therapy, and 23 individuals whom did not (control). Improvements in motor functioning were assessed on all participants using the UPDRS (Unified Parkinson's Disease Rating Scale) up to six months after treatment.
GAD
With further clinical trials, this form of gene therapy will hopefully improve the lives of individuals with Parkinson's disease who do not benefit from drugs.
GADWith further clinical trials, this form of gene therapy will hopefully improve the lives of individuals with Parkinson's disease who do not benefit from drugs.
Subscribe to:
Post Comments (Atom)
I hope that this does work. It would be nice to develop something where improvements happened but not many people were tested. Once they do further studies and tests on people that have PD, then they can certianly conclude their findings. They also have to see if it can last more than 6 months or the person would have to go twice a year. I just hope for the best because it is a sad disease like all others.
ReplyDeleteOnline Article...
ReplyDelete[...]very few websites that happen to be detailed below, from our point of view are undoubtedly well worth checking out[...]...